NMPA Approval

Isophane Protamine Human Insulin Injection

Approval Number

S20201012

Registration Date

February 5, 2020

Previous Approval Numbers

H20171212

Drug Information

Generic Name

精蛋白生物合成人胰岛素注射液

Trade Name

诺和灵N

Dosage Form

注射剂

Strength

810支/箱，1125支/箱

Drug Type

生物制品

Registration Date

February 5, 2020

Expiry Date

September 25, 2022

Company Address

Novo Allé, 2880 Bagsvrd, Denmark

Empowering clinical research with data-driven insights and AI-powered tools.

精蛋白生物合成人胰岛素注射液 - NMPA 批准文号 | MedPath